IL1B and glioma: Coadministration of human BM‐MSCs and glioma cells also significantly reduced tumor size and vascular density, with MSCs downregulating the expression of angiogenic molecules 18 in glioma cells and BM‐MSC glioma cocultures showing reduced expression of PDGF‐B and IL‐1β.